Jounce Therapeutics Widgets and Gadgets
| JNCEDelisted Stock | USD 1.88 0.00 0.00% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- JNCE Jounce Therapeutics
- Latest Jounce Therapeutics Announces Closing of Tender Offer
- JNCE 1.88 0.0
- Low 1.88
- High 1.88
- Alpha 1.02
- Beta -1.25
- Return On Equity -0.25
- Return On Asset -0.14
- Profit Margin (0.62) %
- Operating Margin (0.64) %
- Current Valuation (82.09 M)
- Shares Outstanding 52.64 M
- Shares Owned By Insiders 15.99 %
- Shares Owned By Institutions 85.33 %
- Number Of Shares Shorted 2.02 M
- Price To Earning 10.76 X
- Price To Book 0.27 X
- Price To Sales 7.27 X
- Revenue 82 M
- Gross Profit 27.2 M
- EBITDA (50.16 M)
- Net Income (50.92 M)
- Cash And Equivalents 148.56 M
- Cash Per Share 2.87 X
- Total Debt 11.89 M
- Debt To Equity 0.07 %
- Current Ratio 6.78 X
- Book Value Per Share 3.54 X
- Cash Flow From Operations (28.88 M)
- Short Ratio 0.48 X
- Earnings Per Share (0.96) X
- Target Price 2.0
- Number Of Employees 141
- Beta 0.75
- Market Capitalization 101.59 M
- Total Asset 212.55 M
- Retained Earnings (292.79 M)
- Working Capital 173.66 M
- Current Asset 103.95 M
- Current Liabilities 51.26 M
- Z Score 3.78
- Net Asset 212.55 M
- Rate Of Daily Change 1.0
- Day Median Price 1.88
- Day Typical Price 1.88
- Relative Strength Index 72.45
Market Snapshot Widget Example
DAX Index Germany | 19,405 0.43 | |
Taiwan Weighted Taiwan | 22,948 0.19 | |
PSI 20 Stock Portugal | 6,439 0.47 | |
CROBEX Croatia | 3,124 0.19 | |
Budapest SE Hungary | 79,472 0.1 | |
IDX 30 Jakarta Indonesia | 458.68 2.23 | |
ISEQ 20 Price Ireland | 1,615 0.28 | |
NYSE Comp USA | 20,220 0.48 | |
Tel Aviv 35 Israel | 2,281 0.93 | |
Coreshares Index Tracker South Afric | 1,100 0.09 | |
IPC MEXICO Mexico | 50,228 0.42 | |
KL Technology Malaysia | 60.32 1.96 | |
IBEX 35 Index Spain | 11,712 0.47 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,543 0.29 | |
SPASX Dividend Opportunities Australia | 1,697 0.26 | |
HNX 30 Vietnam | 471.74 0.81 | |
Bucharest BET-NG Romania | 1,213 0.53 | |
AMS Small Cap Netherlands | 1,188 0.40 | |
Oslo Exchange Mutual Norway | 1,426 0.25 | |
BEL Small Belgium | 8,148 0.53 | |
Basic Materials Brazil | 5,781 0.32 | |
Swiss Leader Price Switzerland | 1,933 0.06 | |
Fondo Mutuo ETF Chile | 1,368 0.41 | |
Athens General Comp Greece | 1,406 0.33 | |
Stock Exchange Of Thailand | 1,443 0.21 | |
PX Prague Stock Czech Repub | 1,697 0.37 | |
THE PHILIPPINE STOCK Philippines | 6,850 1.03 | |
WIG 30 Poland | 2,826 0.44 | |
BIST Electricity Turkey | 493.66 0.85 |
Investing Ideas
In addition to having Jounce Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Jounce Therapeutics
Compare Jounce Therapeutics To Peers
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Jounce Stock
If you are still planning to invest in Jounce Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Jounce Therapeutics' history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |